Psoriatic Arthritis Clinical Trials in Houston, Texas

8 studies are recruiting for psoriatic arthritis in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

   Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modif…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Accurate Clinical Research, Houston, Texas

   Locations

   188 in total

   Run by

   Takeda

   See if you can join NCT06671483 on ClinicalTrials.gov

2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UT MD Anderson Cancer Center, Houston, Texas

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

3. Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

   Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Greater Houston Rheumatology ( Site 5103), Houston, Texas

   Locations

   50 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07486960 on ClinicalTrials.gov

4. A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

   Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Biopharma Informatic | Hassan, Houston, Texas

   Locations

   123 in total

   Run by

   Takeda

   See if you can join NCT06671496 on ClinicalTrials.gov

5. Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

   Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) tr…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Novel Research | Abigail Neiman - Houston, TX, Houston, Texas

   Locations

   78 in total

   Run by

   Takeda

   See if you can join NCT07286058 on ClinicalTrials.gov

6. A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

   The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Accurate Clinical Research, Inc, Houston, Texas

   Locations

   55 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06864026 on ClinicalTrials.gov

7. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

   This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of …

   Stage

   Not phased

   Ages

   18 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT04751396 on ClinicalTrials.gov

8. Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

   Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. This study will evaluate the efficacy and safety of targeted therapies t…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Accurate Clinical Research - Houston /ID# 272754, Houston, Texas

   Locations

   37 in total

   Run by

   AbbVie

   See if you can join NCT06865105 on ClinicalTrials.gov